V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270007362 | 270015747 | null | 68 | Curative (C) | 2015-10-03 | 2015-10-04 | OEPA | 2 | N | 270014869 | OEPA |
| 270007363 | 270015747 | 1.64 | 53.8 | Curative (C) | 2016-11-30 | 2016-12-02 | CHLVPP | 2 | N | 270014869 | CHLVPP |
| 270007364 | 270019440 | null | 70 | Curative (C) | 2016-02-04 | 2016-02-16 | HD EuroNet-PHL-C1 OEPA | N | N | 270014872 | OEPA |
| 270007365 | 270019440 | 1.71 | 87.5 | Palliative (P) | 2016-06-02 | 2016-06-15 | Irinotecan + Modified De Gramont | N | N | 270014872 | IRINOTECAN + MDG |
| 270007366 | 270004539 | 1.68 | 74.1 | Curative (C) | 2013-02-25 | 2013-03-25 | Capecitabine 35days + RT | N | Y | 270014874 | CAPECITABINE + RT |
| 270007367 | 270004539 | 1.61 | 31.05 | Curative (C) | 2015-11-01 | 2015-11-01 | CHLVPP | N | null | 270014874 | CHLVPP |
| 270007368 | 270004540 | 1.67 | 80.4 | Palliative (P) | 2017-06-24 | 2017-07-08 | FLUOROURACIL + IRINOTECAN | N | N | 270014879 | IRINOTECAN + MDG |
| 270007369 | 270004541 | 1.75 | 84.4 | Neo-adjuvant (N) | 2014-09-08 | 2014-09-10 | CAPECITABINE + RT | null | Y | 270014880 | CAPECITABINE + RT |
| 270007370 | 270004542 | 1.68 | 155 | Palliative (P) | 2014-01-19 | 2014-02-04 | Irinotecan + Modified De Gramont | null | N | 270014881 | IRINOTECAN + MDG |
| 270007371 | 270004543 | 0 | 70 | Curative (C) | null | 2016-05-04 | HD EuroNet-PHL-C1 OEPA | N | N | 270014882 | OEPA |
| 270007372 | 270004544 | 1.73 | 71.9 | Neo-adjuvant (N) | 2016-08-15 | 2016-08-16 | Capecitabine 35days + RT | N | Y | 270014883 | CAPECITABINE + RT |
| 270007373 | 270004545 | null | 61 | Curative (C) | 2014-02-02 | 2014-02-27 | OEPA | N | N | 270014884 | OEPA |
| 270007374 | 270004545 | 1.66 | 26 | Curative (C) | 2016-04-01 | 2016-04-08 | Capecitabine 35days + RT | 02 | Y | 270014884 | CAPECITABINE + RT |
| 270007375 | 270015748 | 0 | 71.8 | Curative (C) | 2015-10-09 | 2015-10-13 | HD EuroNet-PHL-C1 OEPA | N | null | 270014886 | OEPA |
| 270007376 | 270004546 | 1.96 | 39.1 | Curative (C) | 2017-09-25 | 2017-09-27 | CHLVPP | 02 | N | 270014888 | CHLVPP |
| 270007377 | 270004547 | 1.57 | 58 | Curative (C) | 2017-04-21 | 2017-04-25 | HD EuroNet-PHL-C1 OEPA | 2 | N | 270014889 | OEPA |
| 270007378 | 270012306 | 1.8 | 58.8 | Curative (C) | 2015-09-07 | 2015-09-07 | OEPA | N | N | 270014890 | OEPA |
| 270007379 | 270012306 | 1.58 | 59.8 | Neo-adjuvant (N) | 2016-07-28 | 2016-08-24 | Capecitabine 35days + RT | N | N | 270014890 | CAPECITABINE + RT |
| 270007380 | 270004548 | 1.85 | 111 | Palliative (P) | 2016-02-03 | 2016-02-04 | Irinotecan + Modified De Gramont | N | N | 270014893 | IRINOTECAN + MDG |
| 270007381 | 270004548 | 1.72 | 86.9 | Palliative (P) | 2014-12-05 | 2014-12-10 | IRINOTECAN + MDG | N | N | 270014893 | IRINOTECAN + MDG |
| 270007382 | 270015750 | 1.82 | 95 | Curative (C) | 2016-05-27 | 2016-05-28 | CHLVPP | N | N | 270014896 | CHLVPP |
| 270007383 | 270004549 | 0 | 80.8 | Curative (C) | 2015-09-22 | 2015-09-22 | OEPA | 2 | N | 270014899 | OEPA |
| 270007384 | 270004549 | 0 | 49.3 | Adjuvant (A) | 2015-11-29 | 2015-12-06 | OEPA | null | N | 270014899 | OEPA |
| 270007385 | 270004550 | 1.78 | 78.8 | Palliative (P) | 2017-03-24 | 2017-04-29 | Irinotecan + Modified De Gramont | N | null | 270014901 | IRINOTECAN + MDG |
| 270007386 | 270012309 | 1.64 | 40.8 | Neo-adjuvant (N) | 2014-07-10 | 2014-08-12 | Capecitabine 35days + RT | 02 | Y | 270014902 | CAPECITABINE + RT |
| 270007387 | 270004551 | 1.64 | 71.6 | Disease modification (D) | 2015-10-19 | 2015-10-26 | CHLVPP | N | N | 270014904 | CHLVPP |
| 270007388 | 270004551 | 1.05 | 77.4 | Curative (C) | 2013-06-03 | 2013-06-07 | HD EuroNet-PHL-C1 OEPA | N | N | 270014904 | OEPA |
| 270007389 | 270004552 | 1.84 | 66 | Curative (C) | null | 2016-04-11 | HD EuroNet-PHL-C1 OEPA | N | N | 270014909 | OEPA |
| 270007390 | 270004552 | 1.63 | 55.3 | Palliative (P) | 2016-01-01 | 2016-01-09 | Irinotecan + Modified De Gramont | null | N | 270014909 | IRINOTECAN + MDG |
| 270007391 | 270004553 | 1.63 | 51 | Neo-adjuvant (N) | 2015-11-23 | 2015-12-13 | Capecitabine 35days + RT | N | Y | 270014911 | CAPECITABINE + RT |
| 270007392 | 270004554 | 1.72 | 56.8 | Curative (C) | 2013-04-20 | 2013-05-02 | CHLVPP | N | N | 270014913 | CHLVPP |
| 270007393 | 270004555 | 1.81 | 71 | Curative (C) | 2018-01-03 | 2018-01-04 | CHLVPP | 02 | N | 270014914 | CHLVPP |
| 270007394 | 270004555 | null | 21.6 | Curative (C) | 2013-03-16 | 2013-03-17 | OEPA | null | N | 270014914 | OEPA |
| 270007395 | 270004556 | 1.8 | 27.2 | Curative (C) | 2013-07-26 | 2013-08-03 | CHLVPP | N | null | 270014918 | CHLVPP |
| 270007396 | 270004556 | null | 42.9 | Curative (C) | 2017-11-02 | 2017-11-04 | OEPA | N | N | 270014918 | OEPA |
| 270007397 | 270004557 | 0 | 80 | Curative (C) | 2016-09-29 | 2016-10-10 | OEPA | N | N | 270014920 | OEPA |
| 270007398 | 270004558 | 1.67 | 75 | Curative (C) | 2017-04-10 | 2017-04-10 | OEPA | null | N | 270014921 | OEPA |
| 270007399 | 270004558 | 1.83 | 73.2 | Curative (C) | 2015-12-05 | 2015-12-06 | Capecitabine 35days + RT | null | Y | 270014921 | CAPECITABINE + RT |
| 270007400 | 270004558 | 0 | 39.5 | Curative (C) | 2017-03-28 | 2017-03-28 | HD EuroNet-PHL-C1 OEPA | N | N | 270014921 | OEPA |
| 270007401 | 270004559 | 1.6 | 94 | Neo-adjuvant (N) | 2018-02-17 | 2018-02-27 | Capecitabine 35days + RT | N | Y | 270014924 | CAPECITABINE + RT |
| 270007402 | 270004560 | 1.8 | 76.4 | null | 2016-04-23 | 2016-04-25 | CHLVPP | N | N | 270014925 | CHLVPP |
| 270007403 | 270012315 | 1.32 | 88 | Curative (C) | 2016-01-12 | 2016-01-19 | Capecitabine 35days + RT | 02 | Y | 270014926 | CAPECITABINE + RT |
| 270007404 | 270004561 | 1.65 | 58 | Neo-adjuvant (N) | 2014-12-28 | 2015-01-24 | CAPECITABINE + RT | 02 | Y | 270014927 | CAPECITABINE + RT |
| 270007405 | 270004562 | 1.72 | 78.8 | Palliative (P) | 2016-04-08 | 2016-04-25 | Irinotecan + Modified De Gramont | 02 | N | 270014928 | IRINOTECAN + MDG |
| 270007406 | 270004562 | 1.7 | 111 | Curative (C) | 2016-03-01 | 2016-03-04 | CHLVPP | N | N | 270014928 | CHLVPP |
| 270007407 | 270004563 | 1.66 | 70.8 | Curative (C) | 2014-04-28 | 2014-04-30 | OEPA | N | N | 270014930 | OEPA |
| 270007408 | 270004564 | 1.47 | 122.6 | Curative (C) | 2017-08-09 | 2017-08-10 | CHLVPP | 02 | N | 270014931 | CHLVPP |
| 270007409 | 270004564 | 1.68 | 82.4 | Neo-adjuvant (N) | 2015-03-25 | 2015-04-08 | Capecitabine 35days + RT | 1 | Y | 270014931 | CAPECITABINE + RT |
| 270007410 | 270004565 | 1.66 | 44 | Palliative (P) | 2015-01-15 | 2015-01-29 | Irinotecan + Modified De Gramont | 02 | N | 270014935 | IRINOTECAN + MDG |
| 270007411 | 270004565 | 1.75 | 85.4 | null | 2017-08-27 | 2017-09-02 | OEPA | N | N | 270014935 | OEPA |